Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
‘Day job and a gay job’: LGBTQ+ leaders in biopharma want those who look, talk and love like them to be seen and counted
Biotech Startup Ochre Bio Lands Seed Financing to Combat Liver Diseases
Biotech looks to upset the preclinical model for liver drug development, and now it’s gearing up for the clinic
Liver disease is one of the hardest therapeutic areas to hit, and some researchers have pointed to a dearth of meaningful preclinical models during drug development. Now, a UK biotech has figured out a workaround for its own siRNA liver drugs, and it all starts with discarded human organs. Ochre Bio announced the closing of […]